Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Is she saying that TLT can get fund rather than PP in 2024?

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Mar 28, 2024 6:48pm

118 Views

Post# 35959334

RE:RE:RE:Is she saying that TLT can get fund rather than PP in 2024?

Legit62 wrote: Sounds to me like PPs are thing of the past, off to bigger and better pastures from the sound of that statement, could be wrong, have been wrong before but we are getting close and they are surely looking for the big hit

Yep Legit,

They likely realise more PPs aren't a good look moving towards BTD and partnerships, IMO.

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”